Nicotine: An Addictive Pleasure

Always thought of as addictive, nicotine is now shown to induce a progressive and long-lasting increase of sensitivity in the brain reward systems, reports an online publication from the journal Neuropsychopharmacology.

PRESS RELEASE FROM NEUROPSYCHOPHARMACOLOGY
(www.nature.com/npp/)

This press release is copyrighted to the Journal Neuropsychopharmacology,
the official publication of the American College of Neuropsychopharmacology,
published in partnership with the Nature Publishing Group

Its use is granted only for journalists and news media receiving it directly
from the Nature Publishing Group.

Nicotine: An Addictive Pleasure

DOI: 10.1038/sj.npp.1300905

Always thought of as addictive, nicotine is now shown to induce a
progressive and long-lasting increase of sensitivity in the brain reward
systems, reports an online publication from the journal
Neuropsychopharmacology. In 2003, 45.4 million adults in the United States
were smokers. An estimated 70% of these said they wanted to quit. Previous
studies have concluded that nicotine is an addictive drug on par with heroin
and cocaine and this work may help us understand why it is so hard to kick
the habit.

In the first study of this kind, researchers studied the "pleasure center"
of the brain or the posterior lateral hypothalamus, and found that nicotine
caused the brain to register an enhanced reward value long after intake.
This differs from other drugs of abuse where there is usually a decrease in
brain reward systems.

Paul J. Kenny and Athina Markou found that rats voluntarily consumed
nicotine to increase the reward sensitivity in their brain. With a
relatively low dosage, administered just one hour a day, the brain is
alerted that nicotine is pleasurable and that this feeling is long lasting.
This long-lasting effect may be linked to the addictive properties of
nicotine and why it is not so easy to quit smoking - because your brain
remembers how good the last cigarette was.

Future research will focus on whether this enhanced sensitivity is reversed
with higher nicotine dosages and whether this leads to depression in chronic
smokers. Follow up studies will also investigate the potential role that
nicotine-induced reward hypersensitivity may play in perpetuating the
nicotine habit and the side effects of quitting smoking. One example for
consideration is whether reward hypersensitivity could increase the
appetitive value of food, thereby contributing to the weight gain seen in
former smokers.

Author contact:
Paul J. Kenny (The Scripps Research Institute, Jupiter, FL, USA)
Tel: +1 561 799 8903, E-mail: [email protected]

PRESS CONTACTS...

For media inquiries relating to editorial content/policy for the Journal
Neuropsychopharmacology:
Joyce-Rachel John (Executive Editor - Academic Journals, Nature Publishing
Group, New York, NY, USA)
Tel: +1 212 726 9214; E-mail: [email protected]

For media inquiries relating to embargo policy for the Journal
Neuropsychopharmacology:
Ruth Francis (Nature London)
Tel: +44 20 7843 4562; E-mail: [email protected]

Katharine Mansell (Nature London)
Tel: +44 20 7843 4658; E-mail: [email protected]

For media inquiries relating to the American College of
Neuropsychopharmacology:
Tel: +1 615 324 2360; E-mail: [email protected]

Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd,
dedicated to serving the academic and professional scientific community.
NPG's flagship title, Nature, is the world's most highly-cited weekly
multidisciplinary journal and was first published in 1869. Other
publications include Nature research journals, Nature Reviews, Nature
Clinical Practice, and a range of prestigious academic journals, including
society-owned publications.

NPG is a global company, with headquarters in London and offices in New
York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich and
Basingstoke. For more information, please go to www.nature.com

Published: 28 Sep 2005

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
Journal:
News topics: 
Content type: 
Websites: 

http://www.nature.com/npp/ NEUROPSYCHOPHARMACOLOGY

Reference: 

NEUROPSYCHOPHARMACOLOGY